LEUKEMIA, B-CELL
Clinical trials for LEUKEMIA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lifelong drug access study keeps cancer patients on treatment
Disease control OngoingThis study offers ongoing access to ibrutinib for 297 people with certain blood cancers or graft-versus-host disease who completed earlier ibrutinib trials and still benefit from the drug but cannot get it commercially. Participants continue their current treatment while research…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE4 • Sponsor: Pharmacyclics Switzerland GmbH • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Gene therapy patients monitored for 15 years in safety check
Knowledge-focused ENROLLING_BY_INVITATIONThis study does not provide any new treatment. It follows up to 1,000 adults who previously received CAR T-cell gene therapy for blood cancers like lymphoma, leukemia, or multiple myeloma. The goal is to monitor for long-term side effects, as required by regulators. Participants …
Matched conditions: LEUKEMIA, B-CELL
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC